Market Overview The China Ophthalmic Drugs Market is experiencing explosive growth driven by glaucoma prevalence, anti-glaucoma drug demand, and aging population eye health needs. The market was valued at USD 2.81 billion in 2024 and is projected to grow from USD 2.98 billion in 2025 to USD 5.18 billion by 2035, exhibiting a CAGR of 5.73%. Glaucoma holds the largest application segment share,...